Literature DB >> 29488622

Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study.

Jeffrey Schatz1, Alyssa M Schlenz2, Kelsey E Smith1, Carla W Roberts3.   

Abstract

AIM: To assess the predictive validity of developmental screenings in children with sickle cell disease (SCD) for academic outcomes and stroke risk.
METHOD: Parent questionnaires and medical record data were collected for a cohort receiving developmental screenings between September 2004 and May 2008 as toddlers or early school age. Screening outcomes were dichotomized (positive, negative) by a priori criteria. Questionnaires assessed school and social functioning, services received, and quality of life. Medical record data assessed general SCD morbidity and stroke risk.
RESULTS: Forty-one toddlers (mean age 2y 5mo; 25 males, 16 females) and 49 early school-age children (mean age 6y 5mo; 26 males, 23 females) completed follow-up. The mean follow-up period was 8 years 6 months (range 6.1-10.8y). For toddlers, positive screenings for language delays predicted lower academic performance (p=0.023). For older children, positive screenings for cognitive delays predicted more frequent academic/attentional problems at school (p<0.001), grade retention (p=0.007), and lower academic performance (p=0.001). Positive screenings were associated with an earlier onset of school problems and lower quality of life. Positive screenings for language/cognitive delays predicted increased stroke risk (both p<0.05).
INTERPRETATION: Screening for language or cognitive development in young children with SCD predicts academic outcomes and stroke risk. WHAT THIS PAPER ADDS: Developmental screening predicts academic outcomes in sickle cell disease. Children with concerning language/cognitive screenings have early-onset school difficulties. Developmental screenings may help predict cerebrovascular complications.
© 2018 Mac Keith Press.

Entities:  

Mesh:

Year:  2018        PMID: 29488622     DOI: 10.1111/dmcn.13689

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

Review 1.  Chronic pediatric diseases and risk for reading difficulties: a narrative review with recommendations.

Authors:  Donna Perazzo; Ryan Moore; Nadine A Kasparian; Megan Rodts; Tzipi Horowitz-Kraus; Lori Crosby; Brian Turpin; Andrew F Beck; John Hutton
Journal:  Pediatr Res       Date:  2022-02-04       Impact factor: 3.953

2.  Neurodevelopmental and Mental Health Screening for Patients with Turner Syndrome in Pediatric Endocrine Clinics: Results of a Pediatric Endocrine Society Survey.

Authors:  Shanlee Davis; Canice Crerand; Christa Hutaff-Lee; Talia Thompson; Amy Tishelman; Omar Samara; Hailey Umbaugh; Leena Nahata; Jessica Kremen
Journal:  Horm Res Paediatr       Date:  2021-04-29       Impact factor: 2.852

3.  Tract-specific analysis and neurocognitive functioning in sickle cell patients without history of overt stroke.

Authors:  Yaqiong Chai; Chaoran Ji; Julie Coloigner; Soyoung Choi; Melissa Balderrama; Chau Vu; Benita Tamrazi; Thomas Coates; John C Wood; Sharon H O'Neil; Natasha Lepore
Journal:  Brain Behav       Date:  2021-01-12       Impact factor: 2.708

4.  Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.

Authors:  La'Kita M J Knight; Allison A King; John J Strouse; Paula Tanabe
Journal:  J Pediatr Hematol Oncol       Date:  2021-04-01       Impact factor: 1.289

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.